Article Text
Therapeutics
Review: Specialist programmes and second-generation antipsychotics reduce relapse after first-episode psychosis
Statistics from Altmetric.com
Footnotes
Sources of funding Marqués de Valdecilla Public Foundation – Research Institute (FMV-IFIMAV), Santander, Spain; Colonial Foundation; National Health and Medical Research Council of Australia.
Footnotes
Competing interests None.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions